Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Dermatology

Guidelines for Authors
www.karger.com/drm_guidelines

Submission
Conditions
Peer Review Policy
Types of Papers
Sections
Ethics
Conflicts of Interest
Plagiarism Policy
Arrangement
Color Illustrations
Digital Object Identifier (DOI)
Supplementary Material
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)

Page Charges
Proofs
E-pub First
Reprints



Submission

Only original papers written in English should be submitted online.

Should you experience any problems with your submission, please contact:

Esther Lawrence
Editorial Office 'Dermatology'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1358
Fax +41 61 306 1434
drm@karger.com




Conditions

All manuscripts are subject to editorial review.

Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publisher. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Dermatology' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.




Peer Review Policy

'Dermatology' is a peer-reviewed journal. Our aim is to provide authors with fast and constructive feedback regarding their submitted manuscript. The Editor-in-Chief and international editorial board ensure a thorough and fair peer review and the highest scientific publishing standards. The Editor-in-Chief is responsible for maintaining a high-quality peer review of papers submitted to the journal.




Types of Papers

The journal accepts the following types of papers:

  • Original Papers
  • Review Papers
  • Industry News
  • Basic Science Investigations
  • Clinical Investigations
  • Novel Treatments
  • Surgical Pearls
  • Consensus Guidelines


  • Original Papers: Fully documented reports of original research. They must describe full sets of significant, original experiments in basic science and translational research in dermatology. Consideration for publication is based on originality, novelty, scientific soundness and appropriate analysis. An Abstract, Introduction, Materials and Methods, Results and Discussion sections are required. The abstract should be structured and contain the following parts: Background, Objective, Methods, Results, Conclusion; it should have no more than 250 words. Authors are asked to follow the CONSORT guidelines (www.consort-statement.org) for Original Papers and state in the cover letter that the guidelines have been adhered to. A synopsis of the Material and Methods section must be provided in a flow chart. The detailed paragraph will be published as supplementary material. The submission of raw data as supplementary material is strongly encouraged.

    Review Papers: Comprehensive reviews covering a timely topic by experts in the field. Review Papers are usually invited by the Editor but may be unsolicited. An abstract (not structured) of no more than 250 words is required. Review Papers are not subject to page charges, and color illustrations are reproduced free of charge in the printed edition. All published Review Papers are freely accessible online.

    Surgical Pearls: Presentation of novel surgical techniques and discussion of their advantages compared to current approaches. Papers of this type should include a short video sequence to be published online.

    Consensus Guidelines: Consensus guidelines are welcome from societies or working groups to provide guidance in key and emerging areas in all fields of dermatology.




    Sections

    'International Dermatology Outcome Measures': The section includes papers whose research focus is in alignment with the mission of the non-profit organization 'International Dermatology Outcome Measures' (IDEOM): The development of evidence-based outcomes measures to evaluate the impact of treatments for patients with dermatological diseases. Please view the above 'Types of Papers' list for all different paper categories accepted within this section. All submissions to this section are subject to editorial and peer-review. 'Dermatology' publication conditions apply.

    'Skin Cancer': The section with a thematic focus on 'Skin Cancer' includes papers on any cancers that arise from the skin (basal-cell cancer (BCC), squamous-cell cancer (SCC) and melanoma). Please view the above 'Types of Papers' list for all different paper categories accepted within this section. All submissions to this section are subject to editorial and peer-review. 'Dermatology' publication conditions apply.

    'Tattoo and Body Art': 'Dermatology' welcomes submissions to the section 'Tattoo and Body Art' covering various types of body art and skin modifications (namely tattooing, permanent make-up, body-piercing, scarification, etc.) and including basic research and science on those topics. Please view the above 'Types of Papers' list for all paper categories accepted within this section. All submissions to this section are subject to editorial and peer-review. 'Dermatology' publication conditions apply.




    Ethics

    Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute’s committee on human research. Further, they should also state that animal experiments conform to institutional standards.




    Conflicts of Interest

    Authors are required to disclose any sponsorship or funding arrangements relating to their research, and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.




    Plagiarism Policy

    Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor.




    Arrangement

    Papers should comprise approximately 13 double-spaced manuscripts pages including figures, tables and references. For technical details, please refer to the Technical Instructions.

    Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted and a short title for use as running head.

    Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

    Key words: For indexing purposes, a list of 3–10 key words in English is essential for all papers.

    Key message: Kindly provide a sentence of up to 15 words that capture the essence of the content of the paper.

    Material and Methods: A synopsis of the Material and Methods section must be provided in a flow chart. The detailed paragraph will be published as supplementary material.

    Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.

    Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be stored in separate files. Tables require a heading and figures a legend, also prepared in a separate file.
    When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm) or provide crop marks. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. For further details please refer to the technical Instructions.

    References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as [unpublished data] and not be included in the reference list. The list of references should include only those publications which are cited in the text. Avoid using abstracts and posters as references. If necessary, list as footnotes in standard reference format, followed by the designation ‘(abstr.)’ or ‘(poster)’. For posters, add the details of the meeting where presented.
    Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).

    Examples

    (a) Papers published in periodicals:
    Chatel JM, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:
    14–18.

    (b) Papers published only with DOI numbers:
    Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

    (c) Monographs:
    Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
    ed 3, revised. Basel, Karger, 1996.

    (d) Edited books:
    DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.

    Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.




    Color Illustrations

    All color illustrations will be published in color online and black/white in print. In print, optional publication of illustrations in color is subject to a charge of CHF 960.00 per page.




    Digital Object Identifier (DOI)

    S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org




    Supplementary Material

    Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.




    Self-Archiving/Green Open Access

    Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

    • Be used for noncommercial purposes only
    • Be linked to the final version on www.karger.com
    • Include the following statement:

    ‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

    It is the author’s responsibility to fulfill these requirements.

    For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

    Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

    For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.


    Author's ChoiceTM

    Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
    The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

    • Follow the terms of the relevant Creative Commons license
    • Be linked to the final version on www.karger.com
    • Include the following statement:

    ‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

    It is the author’s responsibility to fulfill these requirements.

    For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.


    Funding Organizations (NIH etc.)

    The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
    Authors should include information on their grant in the Acknowledgements section of their papers.




    Page Charges

    There are no page charges for papers of 3 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00. The allotted size of a paper is equal to approx. 9 double-spaced manuscript pages (including tables, illustrations and references).




    Proofs

    Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer's errors are charged to the author.




    E-pub First

    All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors' approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs.




    Reprints

    Order forms are sent with the proofs. Orders submitted after the issue has been printed are subject to considerably higher prices.